12 min listen
Zuranolone: A New Dawn for Postpartum Depression Treatment
Zuranolone: A New Dawn for Postpartum Depression Treatment
ratings:
Length:
12 minutes
Released:
Apr 1, 2024
Format:
Podcast episode
Description
In this episode, we discuss the groundbreaking FDA approval of zuranolone, the first oral medication specifically targeting postpartum depression. Could zuranolone's novel mechanism of action as an allopregnanolone agonist herald a new era of rapid-onset, targeted treatments for this debilitating condition affecting 1 in 8 new mothers? Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 54 Zuranolone for the Treatment of Postpartum Depression
Released:
Apr 1, 2024
Format:
Podcast episode
Titles in the series (100)
Early Antipsychotic Nonresponse as a Predictor of Nonresponse: In this episode, we discuss whether early nonresponse in adolescents with first-episode psychosis predicts longer-term nonresponse and nonremission. We also explain when it is most likely that symptom improvement occurs and some other considerations... by Psychopharmacology and Psychiatry Updates